A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) | MicrobiomeTrials
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-07-03Est. Completion: 2031-04-01
Enrollment target: 360 participants
Locations
UCLA Hematology & Oncology ( Site 0003), Los Angeles, California, United States
University of California-Irvine Medical Center ( Site 0016), Orange, California, United States
UCSF Medical Center at Mission Bay ( Site 0034), San Francisco, California, United States
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C., District of Columbia, United States
Memorial Sloan Kettering Cancer Center ( Site 0006), New York, New York, United States
UPMC Hillman Cancer Center ( Site 0014), Pittsburgh, Pennsylvania, United States
The West Clinic, PLLC dba West Cancer Center ( Site 0005), Germantown, Tennessee, United States
Fred Hutchinson Cancer Center ( Site 0013), Seattle, Washington, United States
Instituto Alexander Fleming ( Site 0202), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0200), La Rioja, Argentina
Macquarie University-MQ Health Clinical Trials Unit ( Site 0801), Macquarie University, New South Wales, Australia
Liga Norte Riograndense Contra o Câncer ( Site 0271), Natal, Rio Grande do Norte, Brazil
Other microbiome trials you might be interested in
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
The purpose of this phase Ib/II study is to (a) in Phase Ib evaluate the safety, tolerability, and pharmacokinetics (PK)…
El Paso, United StatesEst. completion Jul 10, 2028
MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0270), Porto Alegre, Rio Grande do Sul, Brazil
Hospital Moinhos de Vento ( Site 0278), Porto Alegre, Rio Grande do Sul, Brazil
Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0268), Bragança Paulista, São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) ( Site 0273), Ribeirão Preto, São Paulo, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0263), São José do Rio Preto, São Paulo, Brazil
Hospital Alemao Oswaldo Cruz ( Site 0279), São Paulo, São Paulo, Brazil
IPITEC ( Site 0275), São Paulo, Brazil
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0269), São Paulo, Brazil
BC Cancer - Vancouver Center ( Site 0103), Vancouver, British Columbia, Canada
Sunnybrook Research Institute ( Site 0109), Toronto, Ontario, Canada
Princess Margaret Cancer Centre ( Site 0102), Toronto, Ontario, Canada
Département clinique de médecine de laboratoire du CHUM ( Site 0108), Montreal, Quebec, Canada
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0107), Sherbrooke, Quebec, Canada
Clinica Universidad Catolica del Maule ( Site 0236), Talca, Maule Region, Chile
FALP ( Site 0232), Santiago, Region M. de Santiago, Chile
Centro de Oncología de Precisión ( Site 0241), Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 0231), Santiago, Region M. de Santiago, Chile
ONCOCENTRO APYS ( Site 0234), Viña del Mar, Valparaiso, Chile
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 0498), Bordeaux, Gironde, France
Centre Oscar Lambret ( Site 0495), Lille, Nord, France
Institut De Cancerologie De L Ouest ( Site 0494), Saint-Herblain, Pays de la Loire Region, France
Centre Hospitalier de la Côte Basque ( Site 0496), Bayonne, Pyrenees-Atlantiques, France
centre hospitalier lyon sud ( Site 0497), Pierre-Bénite, Rhone, France
NCT ( Site 0528), Heidelberg, Baden-Wurttemberg, Germany
Universitaetsklinikum Jena ( Site 0525), Jena, Thuringia, Germany
Universitaetsklinikum Hamburg-Eppendorf ( Site 0524), Hamburg, Germany
St Vincent's University Hospital ( Site 0463), Dublin, Dublin, Ireland
Beaumont Hospital, Dublin ( Site 0465), Dublin, Ireland
Tallaght University Hospital ( Site 0462), Dublin, Ireland
Rambam Health Care Campus ( Site 0400), Haifa, Israel
Hadassah Medical Center ( Site 0404), Jerusalem, Israel
Rabin Medical Center ( Site 0402), Petah Tikva, Israel
Sheba Medical Center ( Site 0401), Ramat Gan, Israel
Sourasky Medical Center ( Site 0403), Tel Aviv, Israel
AOU San Luigi Gonzaga di Orbassano ( Site 0434), Orbassano, Torino, Italy
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( Site 0432), Brescia, Italy
Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0431), Milan, Italy
A.O.U. Federico II di Napoli ( Site 0435), Naples, Italy
Fondazione Policlinico Universitario Agostino Gemelli ( Site 0433), Roma, Italy
Ziekenhuis Gelderse Vallei ( Site 0683), Ede, Gelderland, Netherlands
UMC St. Radboud ( Site 0679), Nijmegen, Gelderland, Netherlands
Nij Smellinghe ( Site 0684), Drachten, Provincie Friesland, Netherlands
Auckland City Hospital ( Site 0831), Auckland, New Zealand
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 0590), Poznan, Greater Poland Voivodeship, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0586), Warsaw, Masovian Voivodeship, Poland
Uniwersyteckie Centrum Kliniczne ( Site 0588), Gdansk, Pomeranian Voivodeship, Poland
Szpital Wojewódzki im. M.Kopernika Oddział Onk. Klinicznej z Pododdziałem Chemioterapii Jednodniowej ( Site 0587), Koszalin, West Pomeranian Voivodeship, Poland
Asan Medical Center ( Site 0925), Songpagu, Seoul, South Korea
Severance Hospital Yonsei University Health System ( Site 0924), Seoul, South Korea
Samsung Medical Center ( Site 0926), Seoul, South Korea
ICO L Hospitalet ( Site 0617), L Hospitalet Del Llobregat, Barcelona, Spain
Hospital Universitario Ramon y Cajal ( Site 0620), Madrid, Spain
Hospital Clinico San Carlos ( Site 0618), Madrid, Spain
Hospital Universitario 12 de Octubre ( Site 0622), Madrid, Spain
Hospital Universitario Virgen del Rocio ( Site 0619), Seville, Spain
Taichung Veterans General Hospital ( Site 0902), Taichung, Taiwan
Taipei Veterans General Hospital ( Site 0901), Taipei, Taiwan
Baskent University Dr. Turgut Noyan Research and Training Center ( Site 0650), Adana, Turkey (Türkiye)
Hacettepe Universitesi Tip Fakultesi ( Site 0648), Ankara, Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi Hastanesi ( Site 0653), Ankara, Turkey (Türkiye)
Ankara Bilkent Şehir Hastanesi ( Site 0654), Ankara, Turkey (Türkiye)
Koç Üniversitesi Hastanesi ( Site 0656), Istanbul, Turkey (Türkiye)
Istanbul Universitesi Cerrahpasa ( Site 0649), Istanbul, Turkey (Türkiye)
Recep Tayyip Erdogan University Training and Research Hospital ( Site 0655), Rize, Turkey (Türkiye)
Addenbrooke's Hospital ( Site 0747), Cambridge, Cambridgeshire, United Kingdom
St Bartholomew's Hospital ( Site 0749), London, London, City of, United Kingdom
Royal Free Hospital ( Site 0743), London, London, City of, United Kingdom
Royal Marsden Hospital (Sutton) ( Site 0741), London, Surrey, United Kingdom